Literature DB >> 25460572

The parathyroid hormone-regulated transcriptome in osteocytes: parallel actions with 1,25-dihydroxyvitamin D3 to oppose gene expression changes during differentiation and to promote mature cell function.

Hillary C St John1, Mark B Meyer1, Nancy A Benkusky1, Alex H Carlson1, Mathew Prideaux2, Lynda F Bonewald2, J Wesley Pike3.   

Abstract

Although localized to the mineralized matrix of bone, osteocytes are able to respond to systemic factors such as the calciotropic hormones 1,25(OH)2D3 and PTH. In the present studies, we examined the transcriptomic response to PTH in an osteocyte cell model and found that this hormone regulated an extensive panel of genes. Surprisingly, PTH uniquely modulated two cohorts of genes, one that was expressed and associated with the osteoblast to osteocyte transition and the other a cohort that was expressed only in the mature osteocyte. Interestingly, PTH's effects were largely to oppose the expression of differentiation-related genes in the former cohort, while potentiating the expression of osteocyte-specific genes in the latter cohort. A comparison of the transcriptional effects of PTH with those obtained previously with 1,25(OH)2D3 revealed a subset of genes that was strongly overlapping. While 1,25(OH)2D3 potentiated the expression of osteocyte-specific genes similar to that seen with PTH, the overlap between the two hormones was more limited. Additional experiments identified the PKA-activated phospho-CREB (pCREB) cistrome, revealing that while many of the differentiation-related PTH regulated genes were apparent targets of a PKA-mediated signaling pathway, a reduction in pCREB binding at sites associated with osteocyte-specific PTH targets appeared to involve alternative PTH activation pathways. That pCREB binding activities positioned near important hormone-regulated gene cohorts were localized to control regions of genes was reinforced by the presence of epigenetic enhancer signatures exemplified by unique modifications at histones H3 and H4. These studies suggest that both PTH and 1,25(OH)2D3 may play important and perhaps cooperative roles in limiting osteocyte differentiation from its precursors while simultaneously exerting distinct roles in regulating mature osteocyte function. Our results provide new insight into transcription factor-associated mechanisms through which PTH and 1,25(OH)2D3 regulate a plethora of genes important to the osteoblast/osteocyte lineage.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ChIP-seq; Osteocyte; PTH; RNA-seq; Transcriptional regulation

Mesh:

Substances:

Year:  2014        PMID: 25460572      PMCID: PMC4285334          DOI: 10.1016/j.bone.2014.11.010

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  51 in total

1.  Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo.

Authors:  Stacey M Woo; Jennifer Rosser; Vladimir Dusevich; Ivo Kalajzic; Lynda F Bonewald
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

2.  Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.

Authors:  Qiang Fu; Stavros C Manolagas; Charles A O'Brien
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases.

Authors:  R Vallon; F Freuler; N Desta-Tsedu; A Robeva; J Dawson; P Wenner; P Engelhardt; L Boes; J Schnyder; C Tschopp; R Urfer; G Baumann
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

4.  Matrix-embedded osteocytes regulate mobilization of hematopoietic stem/progenitor cells.

Authors:  Noboru Asada; Yoshio Katayama; Mari Sato; Kentaro Minagawa; Kanako Wakahashi; Hiroki Kawano; Yuko Kawano; Akiko Sada; Kyoji Ikeda; Toshimitsu Matsui; Mitsune Tanimoto
Journal:  Cell Stem Cell       Date:  2013-06-06       Impact factor: 24.633

Review 5.  Molecular mechanisms of vitamin D action.

Authors:  Mark R Haussler; G Kerr Whitfield; Ichiro Kaneko; Carol A Haussler; David Hsieh; Jui-Cheng Hsieh; Peter W Jurutka
Journal:  Calcif Tissue Int       Date:  2012-07-11       Impact factor: 4.333

6.  Targeted deletion of Sost distal enhancer increases bone formation and bone mass.

Authors:  Nicole M Collette; Damian C Genetos; Aris N Economides; LiQin Xie; Mohammad Shahnazari; Wei Yao; Nancy E Lane; Richard M Harland; Gabriela G Loots
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-10       Impact factor: 11.205

Review 7.  Control of RANKL gene expression.

Authors:  Charles A O'Brien
Journal:  Bone       Date:  2009-08-27       Impact factor: 4.398

8.  The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.

Authors:  E N Hatada; A Nieters; F G Wulczyn; M Naumann; R Meyer; G Nucifora; T W McKeithan; C Scheidereit
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.

Authors:  Qiang Fu; Robert L Jilka; Stavros C Manolagas; Charles A O'Brien
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

Review 10.  Effects of PTH on osteocyte function.

Authors:  Teresita Bellido; Vaibhav Saini; Paola Divieti Pajevic
Journal:  Bone       Date:  2012-09-24       Impact factor: 4.398

View more
  17 in total

1.  PTH and Vitamin D Repress DMP1 in Cementoblasts.

Authors:  L Wang; A B Tran; F H Nociti; V Thumbigere-Math; B L Foster; C C Krieger; K R Kantovitz; C M Novince; A J Koh; L K McCauley; M J Somerman
Journal:  J Dent Res       Date:  2015-08-14       Impact factor: 6.116

Review 2.  Epigenetic histone modifications and master regulators as determinants of context dependent nuclear receptor activity in bone cells.

Authors:  J Wesley Pike; Mark B Meyer; Hillary C St John; Nancy A Benkusky
Journal:  Bone       Date:  2015-03-27       Impact factor: 4.398

3.  Epigenetic Plasticity Drives Adipogenic and Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells.

Authors:  Mark B Meyer; Nancy A Benkusky; Buer Sen; Janet Rubin; J Wesley Pike
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

4.  PTH Signaling and Epigenetic Control of Bone Remodeling.

Authors:  Florante Ricarte; Teruyo Nakatani; Nicola Partridge
Journal:  Curr Mol Biol Rep       Date:  2016-02-03

Review 5.  Regulation of Bone Remodeling by Parathyroid Hormone.

Authors:  Marc N Wein; Henry M Kronenberg
Journal:  Cold Spring Harb Perspect Med       Date:  2018-08-01       Impact factor: 6.915

6.  The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D3.

Authors:  Seong Min Lee; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2015-08-29       Impact factor: 4.292

7.  Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.

Authors:  Melda Onal; Hillary C St John; Allison L Danielson; J Wesley Pike
Journal:  J Bone Miner Res       Date:  2016-02       Impact factor: 6.741

8.  Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA/SIK2/SIK3 and PP1/PP2A-CRTC3 signaling.

Authors:  Florante R Ricarte; Carole Le Henaff; Victoria G Kolupaeva; Thomas J Gardella; Nicola C Partridge
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

Review 9.  Genomic Determinants of Vitamin D-Regulated Gene Expression.

Authors:  J Wesley Pike; Mark B Meyer; Nancy A Benkusky; Seong Min Lee; Hillary St John; Alex Carlson; Melda Onal; Sohel Shamsuzzaman
Journal:  Vitam Horm       Date:  2015-11-27       Impact factor: 3.421

10.  Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms.

Authors:  Matthew Prideaux; Sarah L Dallas; Ning Zhao; Erica D Johnsrud; Patricia A Veno; Dayong Guo; Yuji Mishina; Stephen E Harris; Lynda F Bonewald
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.